294 related articles for article (PubMed ID: 16433830)
1. The impact of dydrogesterone supplementation on serum cytokine profile in women with threatened abortion.
Kalinka J; Radwan M
Am J Reprod Immunol; 2006 Feb; 55(2):115-21. PubMed ID: 16433830
[TBL] [Abstract][Full Text] [Related]
2. The impact of dydrogesterone supplementation on hormonal profile and progesterone-induced blocking factor concentrations in women with threatened abortion.
Kalinka J; Szekeres-Bartho J
Am J Reprod Immunol; 2005 Apr; 53(4):166-71. PubMed ID: 15760377
[TBL] [Abstract][Full Text] [Related]
3. Progesterone - induced blocking factor (PIBF) and Th(1)/Th(2) cytokine in women with threatened spontaneous abortion.
Hudić I; Fatusić Z
J Perinat Med; 2009; 37(4):338-42. PubMed ID: 19290853
[TBL] [Abstract][Full Text] [Related]
4. Modulation of cytokine production by dydrogesterone in lymphocytes from women with recurrent miscarriage.
Raghupathy R; Al Mutawa E; Makhseed M; Azizieh F; Szekeres-Bartho J
BJOG; 2005 Aug; 112(8):1096-101. PubMed ID: 16045524
[TBL] [Abstract][Full Text] [Related]
5. Dydrogesterone supplementation in women with threatened preterm delivery--the impact on cytokine profile, hormone profile, and progesterone-induced blocking factor.
Hudić I; Szekeres-Bartho J; Fatušić Z; Stray-Pedersen B; Dizdarević-Hudić L; Latifagić A; Hotić N; Kamerić L; Mandžić A
J Reprod Immunol; 2011 Dec; 92(1-2):103-7. PubMed ID: 22032897
[TBL] [Abstract][Full Text] [Related]
6. Redirection of cytokine production by lymphocytes from women with pre-term delivery by dydrogesterone.
Raghupathy R; Al Mutawa E; Makhseed M; Al-Azemi M; Azizieh F
Am J Reprod Immunol; 2007 Jul; 58(1):31-8. PubMed ID: 17565545
[TBL] [Abstract][Full Text] [Related]
7. Dydrogesterone in threatened abortion: pregnancy outcome.
Omar MH; Mashita MK; Lim PS; Jamil MA
J Steroid Biochem Mol Biol; 2005 Dec; 97(5):421-5. PubMed ID: 16293412
[TBL] [Abstract][Full Text] [Related]
8. Oral dydrogesterone treatment during the first trimester of pregnancy: the prevention of miscarriage study (PROMIS). A double-blind, prospectively randomized, placebo-controlled, parallel group trial.
Walch K; Hefler L; Nagele F
J Matern Fetal Neonatal Med; 2005 Oct; 18(4):265-9. PubMed ID: 16318978
[TBL] [Abstract][Full Text] [Related]
9. Dydrogesterone support in threatened miscarriage.
El-Zibdeh MY; Yousef LT
Maturitas; 2009 Dec; 65 Suppl 1():S43-6. PubMed ID: 20007011
[TBL] [Abstract][Full Text] [Related]
10. Dydrogesterone in threatened miscarriage: a Malaysian experience.
Pandian RU
Maturitas; 2009 Dec; 65 Suppl 1():S47-50. PubMed ID: 20005647
[TBL] [Abstract][Full Text] [Related]
11. Serial estimation of Th1:th2 cytokines profile in women undergoing in-vitro fertilization-embryo transfer.
Kalu E; Bhaskaran S; Thum MY; Vishwanatha R; Croucher C; Sherriff E; Ford B; Bansal AS
Am J Reprod Immunol; 2008 Mar; 59(3):206-11. PubMed ID: 18275514
[TBL] [Abstract][Full Text] [Related]
12. Elevated circulating IL-1beta and TNF-alpha, and unaltered IL-6 in first-trimester pregnancies complicated by threatened abortion with an adverse outcome.
Vitoratos N; Papadias C; Economou E; Makrakis E; Panoulis C; Creatsas G
Mediators Inflamm; 2006; 2006(4):30485. PubMed ID: 17047289
[TBL] [Abstract][Full Text] [Related]
13. Circulating cytokines during early pregnancy in women with recurrent spontaneous abortion: decreased TNF-alpha levels in abortion with normal chromosome karyotype.
Yamada H; Morikawa M; Furuta I; Kato EH; Shimada S; Sata F; Kishi R; Minakami H
Hokkaido Igaku Zasshi; 2004 May; 79(3):237-41. PubMed ID: 15188632
[TBL] [Abstract][Full Text] [Related]
14. The role of dydrogesterone in recurrent (habitual) abortion.
Gruber CJ; Huber JC
J Steroid Biochem Mol Biol; 2005 Dec; 97(5):426-30. PubMed ID: 16188436
[TBL] [Abstract][Full Text] [Related]
15. Intracellular cytokine expression of peripheral blood natural killer cell subsets in women with recurrent spontaneous abortions and implantation failures.
Fukui A; Kwak-Kim J; Ntrivalas E; Gilman-Sachs A; Lee SK; Beaman K
Fertil Steril; 2008 Jan; 89(1):157-65. PubMed ID: 17482605
[TBL] [Abstract][Full Text] [Related]
16. No effect of tocolytic therapy with atosiban on maternal serum interleukin-6 and tumor necrosis factor-alpha in threatened preterm labor.
Vitoratos N; Kountouris A; Makrakis E; Papadias K; Creatsas G
J Matern Fetal Neonatal Med; 2007 Oct; 20(10):725-8. PubMed ID: 17763273
[TBL] [Abstract][Full Text] [Related]
17. Manipulation of cytokine production profiles as a therapeutic approach for immunologic pregnancy loss.
Raghupathy R
Indian J Biochem Biophys; 2008 Aug; 45(4):229-36. PubMed ID: 18788472
[TBL] [Abstract][Full Text] [Related]
18. Modulation of Cytokine Production by the Dydrogesterone Metabolite Dihydrodydrogesterone.
Raghupathy R; Al-Azemi M
Am J Reprod Immunol; 2015 Nov; 74(5):419-26. PubMed ID: 26250154
[TBL] [Abstract][Full Text] [Related]
19. Differences in amniotic fluid and maternal serum cytokine levels in early midtrimester women without evidence of infection.
Chow SS; Craig ME; Jones CA; Hall B; Catteau J; Lloyd AR; Rawlinson WD
Cytokine; 2008 Oct; 44(1):78-84. PubMed ID: 18703348
[TBL] [Abstract][Full Text] [Related]
20. Leptin, IL-10 and inflammatory markers (TNF-alpha, IL-6 and IL-8) in pre-eclamptic, normotensive pregnant and healthy non-pregnant women.
Sharma A; Satyam A; Sharma JB
Am J Reprod Immunol; 2007 Jul; 58(1):21-30. PubMed ID: 17565544
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
